Measures antibodies against acetylcholine receptors, often used to help diagnose myasthenia gravis.
Acetylcholin-Rezept.-AK is often considered in the context of tiredness, reduced capacity, brain fog, or chronic exhaustion. This short overview clarifies what the marker can contribute, where its limits are, and when symptom or illness context becomes more important.
Acetylcholin-Rezept.-AK becomes relevant when low-grade inflammation, immune activity, or recovery questions are part of the picture. It can help flag inflammatory context, but it does not map symptom severity on its own.
Acetylcholin-Rezept.-AK does not explain PEM, delayed worsening after activity, unstable day-to-day function, or a wider multisystem pattern on its own. A single lab value can support interpretation, but it cannot replace symptom timing and longitudinal context.
If fatigue persists, exertion is tolerated poorly, or symptoms escalate after activity, the marker should be linked to a broader fatigue, ME/CFS, PEM, or questionnaire context. That usually makes interpretation far more useful than treating the value as a standalone endpoint.
Acetylcholine receptor antibodies are autoantibodies that target the acetylcholine receptors at the neuromuscular junction. These receptors are essential for transmitting nerve signals to muscles. The test measures the concentration of these antibodies in the blood. It is primarily used as a diagnostic aid for myasthenia gravis, an autoimmune disorder that leads to muscle weakness and fatigue. Elevated levels suggest an autoimmune attack on the acetylcholine receptors.
A result within or below the reference range (commonly 0–0.45 nmol/L, lab-dependent) is generally considered negative. It may suggest that myasthenia gravis is less likely, though a small percentage of patients may still have the condition. Low levels have no known clinical significance.
A value above the reference range (e.g., >0.45 nmol/L, lab-dependent) may indicate the presence of acetylcholine receptor antibodies. This is commonly associated with myasthenia gravis, particularly the generalized form. Higher antibody levels do not always correlate with disease severity. Other autoimmune conditions may occasionally cause a positive result.
This result is not specific for ME/CFS or Long COVID. Read it together with the clinical question, symptoms, related findings and the laboratory reference range rather than in isolation.
Practical details are separated from the general FAQ so they are easier to find.
Acetylcholin-Rezept.-AK becomes relevant when low-grade inflammation, immune activity, or recovery questions are part of the picture. It can help flag inflammatory context, but it does not map symptom severity on its own.
If fatigue persists, exertion is tolerated poorly, or symptoms escalate after activity, the marker should be linked to a broader fatigue, ME/CFS, PEM, or questionnaire context. That usually makes interpretation far more useful than treating the value as a standalone endpoint.
You now know which questions can matter when reading this result. With Elara you can keep the value and its surrounding context together over time.
Save the lab value with its date so individual measurements do not get lost.
See previous measurements together instead of relying on a single snapshot.
View Acetylcholine Receptor Antibody (AChR-Ab) alongside symptom, energy, sleep and PEM entries without assuming one caused the other.
Export your history as a PDF — structured for the next check-up.
Normal levels are typically below 0.45 nmol/L, but reference ranges vary by lab. A result within this range is considered negative.
A high level may suggest myasthenia gravis. However, a positive result must be interpreted alongside clinical symptoms and other tests.
Yes, about 10-15% of patients with generalized myasthenia gravis are seronegative for AChR antibodies. Other antibody tests may be used.
Acetylcholin-Rezept.-AK does not explain PEM, delayed worsening after activity, unstable day-to-day function, or a wider multisystem pattern on its own. A single lab value can support interpretation, but it cannot replace symptom timing and longitudinal context.
For many fatigue-related, inflammatory, hormonal, or recovery-linked markers, interpretation becomes stronger when symptoms, exertion response, and daily function are considered together.
Acetylcholin-Rezept.-AK is rarely meaningful in isolation when fatigue, brain fog, or unstable capacity are central. The fatigue hub provides the broader lab-and-symptom context.
If symptoms worsen after activity with a delay, PEM often explains more than an isolated lab value alone.
Questionnaires help connect biomarkers to symptom patterns, functional limits, and patient-reported change over time.
Markers from the same system can add useful context when a single lab value is hard to interpret on its own.
No individual medical review is documented.
This English content was created with AI assistance and automatically validated. This is not an individual medical review.
These references support the information presented on this page.
This information does not replace medical advice. Lab values should be assessed in the context of your medical history, the reason for testing and other findings. Elara provides health information for orientation — not diagnoses or treatment decisions.
Bring your lab values, symptoms and energy into one shared context — so you walk into your next appointment more informed and structured.
